Your browser doesn't support javascript.
loading
WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.
Vinh Nguyen, Phuoc; Hervé-Aubert, Katel; Lajoie, Laurie; Misericordia, Yoann; Chourpa, Igor; David, Stéphanie; Allard-Vannier, Emilie.
Afiliação
  • Vinh Nguyen P; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Hervé-Aubert K; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France.
  • Lajoie L; ISP UMR1282, INRAE, équipe BioMAP, Université de Tours, Tours, France.
  • Misericordia Y; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France.
  • Chourpa I; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France.
  • David S; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France.
  • Allard-Vannier E; EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France. Electronic address: emilie.allard@univ-tours.fr.
Int J Pharm ; 632: 122335, 2023 Feb 05.
Article em En | MEDLINE | ID: mdl-36283640
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article